Welcome to Novo Nordisk in the United States


National Obesity Care Week

With strong expertise in chronic diseases, including obesity, Novo Nordisk supports the vision of National Obesity Care Week, an annual national initiative to inspire a coalition effort to achieve a comprehensive, compassionate, and patient-centric approach to obesity care. Through this initiative, as well as efforts around research and product development, Novo Nordisk aims to inspire a new, science-based approach to weight management and support individuals struggling with obesity to achieve better health.

Obesity is recognized as a chronic disease by leading medical organizations, including the American Medical Association, American Association of Clinical Endocrinologists, American Academy of Family Physicians, and The Obesity Society.1-4 Despite this, many people with obesity still lack the support they need to manage their weight.5 Health care professionals can play a critical role in this effort by partnering with their patients to develop comprehensive and individualized approaches to weight loss and weight management.6,7 Clear and effective physician-initiated conversations can help increase patient comfort levels and encourage patients to use the full range of resources available.8




  1. American Medical Association House of Delegates. Recognition of obesity as a disease. Resolution 420 (A-13). http://www.npr.org/documents/2013/jun/ama-resolution-obesity.pdf. Received May 15, 2013. Accessed December 8, 2015.
  2. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists' Position Statement on Obesity and Obesity Medicine. Endocrine Practice. 2012;18:642-648.
  3. McKinney L. Diagnosis and Management of Obesity. American Academy of Family Physicians (AAFP). http://www.aafp.org/dam/AAFP/documents/patient_care/fitness/obesity-diagnosis-management.pdf. Published 2013. Accessed August 5, 2015.
  4. Allison DB, Downey M, Atkinson RL, et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity. 2008;16(6):1161-1177.
  5. Puhl RM, Huer CA. Obesity stigma: important considerations for public health. Am J Pub Health. 2010;100(6)1019-1028.
  6. Jensen MD, Ryan DH, Apovian CM, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25ptB):2985-3023.
  7. Obesity Education Initiative; National Heart, Lung, and Blood Institute; National Institutes of Health; US Department of Health and Human Services; Identification, evaluation, and treatment of overweight and obesity in adults: The practical guide. Bethesda, MD: National Institutes of Health; 2000. NIH publication 00-4084.
  8. Loureiro ML, Nayga RM Jr. Obesity, weight loss, and physician’s advice. Soc Sci Med. 2006;62(10):2458-2468.



© 2016 Novo Nordisk All rights reserved. USA15SAM01282 April 2016